Hem001
Research payments
$143,802
Through program year 2025, $143,802 in research payments was reported against Hem001, across 22 payments, paid by Davol Inc..
- Paid by
- Davol Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $102,557 | 17 |
| 2024 | Research | $32,895 | 4 |
| 2023 | Research | $8,350 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Geoffrey Roelant Eau Claire, WI Named on 2 payments
- Aaron Ahearn Los Angeles, CA Named on 1 payment
- Joseph Patterson Los Angeles, CA Named on 1 payment
- Badar Mian Albany, NY Named on 1 payment
- Keith Allen Kansas City, MO Named on 1 payment
- Robert Hawkins Ann Arbor, MI Named on 1 payment
- Charles Broome San Antonio, TX Named on 1 payment
- Jason Engel Washington, DC Named on 1 payment
- Kethandapatti Balaji Jacksonville, FL Named on 1 payment
- Nicholas Brown Wichita, KS Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.